Formoterol/fluticasone propionate - Dey

Drug Profile

Formoterol/fluticasone propionate - Dey

Alternative Names: Fluticasone propionate/formoterol - Dey

Latest Information Update: 24 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dey LP
  • Developer Mylan
  • Class Antiallergics; Antiasthmatics; Ethanolamines; Glucocorticoids; Small molecules
  • Mechanism of Action Beta 2 adrenergic receptor agonists; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Suspended Chronic obstructive pulmonary disease

Most Recent Events

  • 02 Feb 2015 Suspended - Phase-II for Chronic obstructive pulmonary disease in USA (Inhalation)
  • 02 Feb 2015 Suspended - Phase-III for Chronic obstructive pulmonary disease (In the elderly, In adults) in Hungary, Belgium, Slovakia, Sweden and Denmark (Inhalation)
  • 06 Nov 2014 Phase-III clinical trials in Chronic obstructive pulmonary disease (In the elderly, In adults) in Belgium (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top